All In Biotech

Free tool

FAERS Monitor: Prohance Multipack

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021489 or its brand name (Prohance Multipack, Gadoteridol). Reports on generic versions are filed under their own applications.

Reports

1,816

Serious

1,516

83% of reports

Hospitalization

380

Death reported

162

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nephrogenic systemic fibrosis587
  • pain407
  • anxiety254
  • emotional distress223
  • mobility decreased186
  • general physical health deterioration184
  • fibrosis183
  • injury178
  • scar159
  • skin hypertrophy154
  • skin induration151
  • pruritus147
  • dyspnoea142
  • skin tightness137
  • nausea131

Reports by year received

View as table
YearReports
200427
200528
200641
200742
200847
200970
2010176
2011208
201292
201350
2014121
201533
201664
201778
201885
201993
202085
2021125
202268
202363
202475
202562
202683

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,343 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nephrogenic systemic fibrosisSignal5872791.22583.11,317,486
skin indurationSignal151909.8776.0126,277
fibrosisSignal183732.3635.3125,035
skin hypertrophySignal154671.4574.596,826
skin tightnessSignal137347.4294.945,615
scarSignal159108.693.516,694
mobility decreasedSignal18630.126.25,201
injurySignal17829.425.64,858
emotional distressSignal22321.418.94,327
general physical health deteriorationSignal18418.416.13,031
anxietySignal25410.39.22,162
painSignal4077.77.02,427
pruritusSignal1474.43.8394
dyspnoeaSignal1422.92.5180
nausea1311.91.659

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.